ArticleCureus2023
Risk Factors for Readmission in Heart Failure Within 90 Days.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06897410 (Reforça't), which is not on this map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Reforça't: A Randomized Community Clinical Trial With a Social and Healthcare Approach to Improve Functional Outcomes in Patients With Chronic Cardiac, Respiratory, or Mixed Conditions After Hospital Discharge
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
- Deep Learning-Based Prediction of Heart Failure Readmission Using Longitudinal Cardiac Device Data.Journal of cardiovascular electrophysiology · 2026Article
- Evidence on strategies promoting discharge planning participation in patients with chronic heart failure: A scoping review protocol.PloS one · 2026Article
- Wearable technologies to predict and prevent and heart failure hospitalizations: a systematic review.European heart journal. Digital health · 2025Review
- Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction.Journal of the American Heart Association · 2025Article
- Limited predictive value of traditional comorbidities for readmission in acute decompensated heart failure.PloS one · 2025Article
- Prediction of 90 day readmission in heart failure with preserved ejection fraction by interpretable machine learning.ESC heart failure · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital readmission rates among heart failure (HF) patients remain a persistent challenge. While various risk factors have been identified, their impact on individual patients varies, and not all patients with these risk factors will necessarily experience readmission within 90 days. This study aimed to identify and assess the significance of risk factors associated with readmission of HF patients within 90 days.
methodsA retrospective cohort study was conducted at King Abdulaziz University Hospital in Jeddah, Saudi Arabia. The sample size comprised 130 patients. Data was collected from hospital records of all HF patients readmitted within 90 days of discharge between 2018 and 2022.
resultsThe study included 130 patients. The majority (70%) were between 51 and 70 years old. Most patients had a hospital stay ranging from 1 to 10 days (83.1%). Shortness of breath (SOB) was the most common reason for readmission, accounting for 80% of cases. Other reasons included chest pain (CP) (6.2%), orthopnea (13.1%), paroxysmal nocturnal dyspnea (PND) (5.4%), lower limb edema (LLE) issues (1.5%), and heart failure (HF) itself (2.3%). Less common reasons included fever (1.5%), pneumonia (1.5%), altered level of consciousness (1.5%), and urinary tract infection (1.5%).
conclusionReadmission rates for HF patients remain high, attributed to factors such as non-adherence to medication and lifestyle changes, comorbidities, inadequate discharge planning, and social determinants of health. Males may be more prone to experiencing SOB and subsequently requiring readmission at a higher rate. These findings underscore the need for comprehensive interventions that address these risk factors to minimize readmission rates and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.